Status:
COMPLETED
Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris
Lead Sponsor:
Galderma R&D
Conditions:
Acne
Eligibility:
All Genders
12-35 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the tolerability of 3 treatment regimens containing Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel with that of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel standard d...
Eligibility Criteria
Inclusion
- Male or female Subjects of any race, aged 12 to 35 years inclusive
- Subjects with mild or moderate facial acne vulgaris
- Subjects with skin phototype I to IV
Exclusion
- Subjects with more than 1 nodules or cysts on the face,
- Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne, etc.)
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT00883233
Start Date
April 1 2009
End Date
September 1 2009
Last Update
February 18 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Galderma Investigational Site
Windsor, Ontario, Canada
2
Galderma Investigational Site
Montreal, Quebec, Canada